Ocugen, Inc. (OCGN) reporting calendar
Ocugen, Inc. files periodic reports with the SEC as OCGN on Nasdaq. Atlas tracks 46 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 25 Jul 2026 – 22 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 8 May 2026
- Reports on record
- 46
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open OCGN market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 8 May 2026 | 38 days | 0001628280-26-032454 |
| 10-K | 31 Dec 2025 | 4 Mar 2026 | 63 days | 0001628280-26-014435 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001372299-25-000013 |
| 10-Q | 30 Jun 2025 | 4 Aug 2025 | 35 days | 0001628280-25-037310 |
| 10-Q | 31 Mar 2025 | 9 May 2025 | 39 days | 0001628280-25-024093 |
| 10-K | 31 Dec 2024 | 5 Mar 2025 | 64 days | 0001628280-25-010271 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0001628280-24-047846 |
| 10-Q | 30 Jun 2024 | 8 Aug 2024 | 39 days | 0001628280-24-035822 |
| 10-Q | 31 Mar 2024 | 14 May 2024 | 44 days | 0001628280-24-023038 |
| 10-K | 31 Dec 2023 | 16 Apr 2024 | 107 days | 0001628280-24-016378 |
| 10-Q | 30 Sep 2023 | 9 Nov 2023 | 40 days | 0001628280-23-038008 |
| 10-Q | 30 Jun 2023 | 21 Aug 2023 | 52 days | 0001628280-23-030128 |
| 10-Q | 31 Mar 2023 | 5 May 2023 | 35 days | 0001628280-23-016011 |
| 10-K | 31 Dec 2022 | 28 Feb 2023 | 59 days | 0001628280-23-005382 |
| 10-Q | 30 Sep 2022 | 8 Nov 2022 | 39 days | 0001628280-22-028775 |
| 10-Q | 30 Jun 2022 | 5 Aug 2022 | 36 days | 0001628280-22-021255 |
| 10-Q | 31 Mar 2022 | 6 May 2022 | 36 days | 0001628280-22-012850 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0001628280-22-004085 |
| 10-Q | 30 Sep 2021 | 9 Nov 2021 | 40 days | 0001628280-21-022421 |
| 10-Q | 30 Jun 2021 | 6 Aug 2021 | 37 days | 0001628280-21-015998 |
| 10-Q | 31 Mar 2021 | 7 May 2021 | 37 days | 0001628280-21-009457 |
| 10-K | 31 Dec 2020 | 19 Mar 2021 | 78 days | 0001628280-21-005124 |
| 10-Q | 30 Sep 2020 | 6 Nov 2020 | 37 days | 0001628280-20-015862 |
| 10-Q | 30 Jun 2020 | 14 Aug 2020 | 45 days | 0001628280-20-012662 |
| 10-Q | 31 Mar 2020 | 8 May 2020 | 38 days | 0001628280-20-007094 |
| 10-K | 31 Dec 2019 | 27 Mar 2020 | 87 days | 0001628280-20-004221 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001104659-19-062626 |
| 10-Q | 30 Jun 2019 | 9 Aug 2019 | 40 days | 0001193125-19-217994 |
| 10-Q | 31 Mar 2019 | 15 May 2019 | 45 days | 0001193125-19-147982 |
| 10-K | 31 Dec 2018 | 22 Mar 2019 | 81 days | 0001564590-19-008830 |
| 10-Q | 30 Sep 2018 | 8 Nov 2018 | 39 days | 0001564590-18-028656 |
| 10-Q | 30 Jun 2018 | 9 Aug 2018 | 40 days | 0001564590-18-021035 |
| 10-Q | 31 Mar 2018 | 10 May 2018 | 40 days | 0001564590-18-012937 |
| 10-K | 31 Dec 2017 | 15 Mar 2018 | 74 days | 0001564590-18-005711 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001193125-17-338756 |
| 10-Q | 30 Jun 2017 | 10 Aug 2017 | 41 days | 0001193125-17-254439 |
| 10-Q | 31 Mar 2017 | 11 May 2017 | 41 days | 0001193125-17-167282 |
| 10-K | 31 Dec 2016 | 16 Mar 2017 | 75 days | 0001193125-17-085372 |
| 10-Q | 30 Sep 2016 | 10 Nov 2016 | 41 days | 0001193125-16-765874 |
| 10-Q | 30 Jun 2016 | 11 Aug 2016 | 42 days | 0001193125-16-679283 |
Source: SEC EDGAR company submissions for CIK 0001372299. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.